glp 1 and psoriatic arthritis Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity psoriasis: diabetes meets dermatology | Diabetologia Which PsO Patients Can Benefit

Raj Rai, Sristi, Camelia Bhattacharyya, Anwita Sarkar, Surupa Chakraborty, Esha Sircar, Sreejita Dutta, et Rajib Sengupta

, , GHRP-2 6

The level of LPO in groups 5 and 6 completely resumed back to the control (group 1) range, whereas, despite a significant decline in group 4 on day 30, it remained significantly higher than the control group (group 1)

Losing weight is an incredible achievement

The study was funded by the National Institutes of Health.

This can produce irregular cycles, missed periods, or changes in cycle length and flow, particularly in women who lose weight quickly in the early months of treatment